First Time Loading...
I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 250 KRW -0.15%
Updated: Jun 10, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

27.4B
+41%
Operating Cash Flow
Growth Rates:
1 Year
+39%
3 Years
-56%
5 Years
-6%
7 Years
+8%
10 Years
-
-15.7B
+75%
Investing Cash Flow
Growth Rates:
1 Year
+57%
3 Years
+47%
5 Years
0%
7 Years
-48%
10 Years
+21%
-6.5B
+6%
Financing Cash Flow
Growth Rates:
1 Year
+66%
3 Years
+73%
5 Years
+68%
7 Years
-9%
10 Years
-

Cash Flow Statement
Ilyang Pharmaceutical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: KRW
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
3 963
1 375
(2 377)
(4 888)
(5 657)
937
3 184
8 304
12 417
11 115
14 557
11 963
11 260
12 605
11 193
12 941
16 140
15 740
14 689
3 251
3 976
3 688
9 675
19 595
17 551
18 894
20 691
21 545
19 571
20 692
22 832
25 956
32 350
33 684
34 985
31 741
25 087
15 841
9 634
112
(204)
Depreciation & Amortization
5 158
7 561
7 980
9 390
10 668
11 129
11 136
9 339
12 424
12 090
11 788
11 387
11 423
12 049
11 590
11 701
12 896
12 990
12 430
12 019
10 662
10 727
11 907
10 090
10 101
10 018
10 291
12 664
12 867
13 031
13 287
12 650
12 659
12 457
12 512
13 065
13 338
13 490
13 533
13 604
13 107
Change in Deffered Taxes
(820)
(580)
(824)
(533)
0
0
0
0
0
0
0
0
0
0
0
0
0
(370)
(23)
(676)
(974)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
1 122
3 696
4 595
5 572
12 750
12 293
13 566
11 914
15 245
15 454
14 055
10 448
10 351
13 046
13 518
12 484
12 152
9 611
10 736
12 933
14 512
17 026
15 317
19 255
17 060
14 936
16 296
11 909
12 555
13 857
14 181
19 730
20 098
17 978
19 114
12 168
11 583
13 467
11 867
24 135
21 690
Cash Taxes Paid
1 577
2 009
592
2 927
3 413
3 356
7 999
4 532
7 703
7 293
3 958
12 483
5 577
6 293
6 697
(1 798)
(583)
(764)
(1 862)
(3 591)
(2 836)
4 617
5 168
12 424
27 990
11 899
17 007
15 299
8 628
13 634
10 632
6 264
2 697
8 404
8 924
9 109
7 692
5 214
2 927
3 104
2 082
Cash Interest Paid
8 385
10 550
8 560
8 260
7 103
6 584
6 099
4 746
6 218
5 898
5 588
5 395
5 148
5 037
5 106
4 881
4 831
4 805
4 516
4 560
4 452
4 350
4 300
4 160
3 969
3 736
3 416
3 073
2 716
2 376
2 115
2 076
2 041
2 069
2 226
2 423
2 785
3 161
3 518
3 778
3 937
Change in Working Capital
(12 460)
(23 176)
(12 441)
(10 586)
747
4 672
4 950
(7 768)
(13 834)
(12 965)
(10 347)
(6 757)
(7 787)
(6 084)
(11 504)
(7 101)
(6 725)
(11 240)
(4 091)
(5 408)
984
(4 855)
(15 137)
(12 747)
(16 394)
(11 165)
2 543
11 366
16 885
20 335
20 875
8 684
(4 076)
(7 194)
(20 183)
(27 037)
(30 374)
(24 224)
(21 118)
(18 469)
(7 235)
Cash from Operating Activities
(3 036)
N/A
(11 124)
-266%
(3 065)
+72%
(1 044)
+66%
18 507
N/A
28 791
+56%
32 846
+14%
21 788
-34%
26 251
+20%
25 693
-2%
30 054
+17%
27 041
-10%
25 246
-7%
31 615
+25%
24 796
-22%
30 025
+21%
34 465
+15%
26 732
-22%
33 742
+26%
22 120
-34%
29 159
+32%
26 281
-10%
21 110
-20%
36 193
+71%
28 616
-21%
32 683
+14%
49 820
+52%
57 484
+15%
61 879
+8%
67 915
+10%
71 174
+5%
67 020
-6%
61 031
-9%
56 925
-7%
46 428
-18%
29 936
-36%
19 634
-34%
18 573
-5%
13 915
-25%
19 382
+39%
27 357
+41%
Investing Cash Flow
Capital Expenditures
(18 824)
(22 054)
(16 248)
(16 639)
(20 447)
(21 610)
(25 535)
(21 570)
(24 681)
(22 539)
(18 778)
(10 307)
(10 152)
(9 854)
(8 462)
(9 115)
(7 989)
(8 286)
(6 248)
(9 679)
(11 210)
(10 508)
(12 327)
(8 385)
(8 999)
(15 436)
(21 752)
(24 622)
(33 217)
(27 378)
(25 305)
(21 352)
(14 399)
(13 984)
(19 757)
(20 535)
(18 882)
(19 577)
(9 213)
(12 005)
(13 040)
Other Items
(1 055)
(950)
(305)
(233)
29
(1 423)
(266)
(304)
(461)
1 215
(322)
(367)
(464)
(934)
(4 263)
(3 872)
(634)
(4 427)
(2 964)
(1 746)
(4 459)
1 987
3 642
7 170
6 769
7 299
7 720
3 462
3 628
693
645
8
(58)
60
96
28 121
(17 734)
(16 933)
(19 382)
(50 603)
(2 639)
Cash from Investing Activities
(19 879)
N/A
(23 005)
-16%
(16 553)
+28%
(16 871)
-2%
(20 418)
-21%
(23 032)
-13%
(25 801)
-12%
(21 874)
+15%
(25 141)
-15%
(21 324)
+15%
(19 100)
+10%
(10 674)
+44%
(10 617)
+1%
(10 788)
-2%
(12 725)
-18%
(12 987)
-2%
(8 623)
+34%
(12 713)
-47%
(9 212)
+28%
(11 425)
-24%
(15 669)
-37%
(8 521)
+46%
(8 685)
-2%
(1 215)
+86%
(2 230)
-84%
(8 137)
-265%
(14 033)
-72%
(21 160)
-51%
(29 589)
-40%
(26 685)
+10%
(24 659)
+8%
(21 344)
+13%
(14 457)
+32%
(13 924)
+4%
(19 661)
-41%
7 585
N/A
(36 616)
N/A
(36 510)
+0%
(28 595)
+22%
(62 608)
-119%
(15 679)
+75%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1 294)
(2 739)
(3 000)
(3 000)
0
(1 904)
(2 000)
(2 000)
0
Net Issuance of Debt
22 033
46 101
25 255
20 820
17 720
(9 017)
(5 891)
(2 885)
(5 097)
256
(372)
(9 046)
(3 780)
(6 258)
(5 501)
(654)
(1 482)
(12 099)
(8 463)
(9 410)
(16 617)
(7 703)
(10 862)
(15 873)
(9 101)
(4 877)
(12 298)
(25 918)
(18 902)
(31 914)
(27 848)
(2 829)
(31 275)
(19 215)
(17 144)
(16 637)
7 680
11 573
6 650
(1 062)
237
Cash Paid for Dividends
(1 755)
(5 505)
(3 854)
(3 854)
(6 564)
(6 907)
(2 710)
(2 072)
(3 063)
1 045
(4 684)
(3 528)
(2 537)
(7 791)
(6 177)
(5 259)
(6 170)
(934)
(1 991)
(1 979)
(3 499)
(3 528)
(3 674)
(5 815)
(9 276)
(7 919)
(6 695)
(4 902)
(5 335)
(8 939)
(9 012)
(8 773)
(2 650)
(4 111)
(4 037)
(3 942)
(3 942)
(3 889)
(3 878)
(3 876)
(4 761)
Other
(16)
64
66
6 351
60
(110)
(128)
(106)
(127)
18
154
271
315
265
180
90
63
(62)
(123)
(142)
(125)
25
42
35
25
(13)
(23)
(142)
(137)
(125)
(144)
(31 524)
(10 203)
(5 925)
(4 141)
184
0
(25 434)
(27 222)
(22)
(18)
Cash from Financing Activities
20 262
N/A
40 660
+101%
21 468
-47%
23 317
+9%
11 216
-52%
(16 034)
N/A
(8 731)
+46%
(5 063)
+42%
(8 287)
-64%
1 319
N/A
(4 901)
N/A
(12 303)
-151%
(6 002)
+51%
(13 784)
-130%
(11 498)
+17%
(5 823)
+49%
(7 590)
-30%
(13 095)
-73%
(10 577)
+19%
(11 531)
-9%
(20 240)
-76%
(11 205)
+45%
(14 494)
-29%
(21 654)
-49%
(18 353)
+15%
(12 810)
+30%
(19 016)
-48%
(30 961)
-63%
(24 374)
+21%
(40 978)
-68%
(37 004)
+10%
(43 127)
-17%
(45 422)
-5%
(31 989)
+30%
(28 322)
+11%
(23 396)
+17%
(19 114)
+18%
(19 654)
-3%
(26 451)
-35%
(6 960)
+74%
(6 543)
+6%
Change in Cash
Effect of Foreign Exchange Rates
0
(185)
188
40
471
712
541
118
27
(224)
(960)
(220)
(1 114)
(250)
854
(977)
480
(225)
(1 837)
(510)
(179)
(276)
799
365
507
309
653
82
147
981
2 116
3 841
3 351
3 543
3 765
(2 261)
(2 422)
(3 461)
(5 025)
73
37
Net Change in Cash
(2 653)
N/A
6 346
N/A
2 038
-68%
5 442
+167%
9 776
+80%
(9 563)
N/A
(1 145)
+88%
(5 031)
-339%
(7 150)
-42%
5 464
N/A
5 093
-7%
3 844
-25%
7 513
+95%
6 793
-10%
1 427
-79%
10 238
+617%
18 732
+83%
699
-96%
12 116
+1 633%
(1 346)
N/A
(6 929)
-415%
6 279
N/A
(1 270)
N/A
13 689
N/A
8 540
-38%
12 045
+41%
17 424
+45%
5 445
-69%
8 063
+48%
1 233
-85%
11 628
+843%
6 390
-45%
4 503
-30%
14 555
+223%
2 210
-85%
11 865
+437%
(38 518)
N/A
(41 052)
-7%
(46 156)
-12%
(50 112)
-9%
5 173
N/A
Free Cash Flow
Free Cash Flow
(21 860)
N/A
(33 178)
-52%
(19 313)
+42%
(17 683)
+8%
(1 940)
+89%
7 181
N/A
7 311
+2%
218
-97%
1 570
+620%
3 154
+101%
11 276
+258%
16 734
+48%
15 094
-10%
21 761
+44%
16 334
-25%
20 910
+28%
26 476
+27%
18 446
-30%
27 494
+49%
12 441
-55%
17 949
+44%
15 773
-12%
8 783
-44%
27 808
+217%
19 617
-29%
17 247
-12%
28 068
+63%
32 862
+17%
28 662
-13%
40 537
+41%
45 869
+13%
45 668
0%
46 631
+2%
42 941
-8%
26 671
-38%
9 401
-65%
752
-92%
(1 004)
N/A
4 702
N/A
7 377
+57%
14 317
+94%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 145,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.